Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yu V Rumyantseva"'
Autor:
A I Karachunsky, Yu V Rumyantseva, S N Lagoiko, C Bührer, G Tallen, O V Aleinikova, O I Bydanov, N V Korepanova, L V Baidun, T V Nasedkina, A Von Stackelberg, G A Novichkova, A A Maschan, D V Litvinov, N I Ponomareva, K L Kondratchik, E G Mansurova, L G Fechina, O V Streneva, N B Yudina, G R Sharapova, A V Shamardina, I E Gerbek, A P Shapochnik, A G Rumyantsev, G Henze
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 41-50 (2015)
Aim. To determine predictors for decision-making on a differential approach to choosing glucocorticosteroids (GCS) for children and adolescents with acute lymphoblastic leukemia (ALL). Subjects and methods. The analysis covered 1064 primary patients
Externí odkaz:
https://doaj.org/article/147f5ec7da0240dfa743df8a897f13a9
Autor:
Yu V Rumyantseva, A I Karachunsky, O V Aleinikova, L G Fechina, A V Shamardina, D V Litvinov, N I Ponomareva, E G Boichenko, S A Dudkin, O V Streneva, K L Kondratchik, E G Mansurova, L M Minkina, E S Lapotentova, E V Inyushkina, N B Yudina, G P Pavlova, E V Zhukovskaya, O P Khlebnikova, S N Lagoiko, E V Basharova, R E Denisov, V D Zlobina, E S Banshchikova, K S Aslanyan, E V Kondakova, E V Tselousova, N V Myakova, T V Turobova, O V Ryskal, N F Chipsanova, S R Varfolomeyeva, A G Rumyantsev
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 11-19 (2010)
Aim. To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. Subjects and methods. A total of 1873 primary patients with ALL aged 1 to 18 years, of w
Externí odkaz:
https://doaj.org/article/cfbc2ada713446ef93c73a86b57fd3bc
Autor:
D D Baidildina, M A Maschan, E V Skorobogatova, M E Dubrovina, Yu V Rumyantseva, A A Maschan, A G Rumyantsev, E V Samochatova
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 20-25 (2010)
Aim. To analyze the specific features of recurrences of acute promyelocytic leukemia (APL) in children after standard therapy with daunorubicin, cytosine arabinoside (Ara-C), all-trans retinoic acid (ATRA) and to develop further programmed treatment
Externí odkaz:
https://doaj.org/article/5e62b3f9a57b4cd8bfe665f6abeecb61
Allele-specific PCR with fluorescently labeled probes: criteria for selecting primers for genotyping
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 28, Iss 3, Pp 351-359 (2024)
Single-nucleotide polymorphisms (SNPs) can serve as reliable markers in genetic engineering, selection, screening examinations, and other fields of science, medicine, and manufacturing. Whole-genome sequencing and genotyping by sequencing can detect
Externí odkaz:
https://doaj.org/article/c965d4724b4047eebe50066cb981c664
Autor:
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 25-33 (2022)
The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG) children and adolescents with acute lymphoblastic leukemia (ALL) treated by the ALL-MB-2002 protoc
Externí odkaz:
https://doaj.org/article/273ffc5c215a492e9db3020d5e11e678
Autor:
E. V. Samochatova, D. D. Baidildina, M. A. Maschan, N. N. Savva, O. P. Khlebnikova, A. V. Shamardina, Yu. E. Mareiko, G. A. Tsaur, T. O. Riger, M. M. Shneider, Yu. V. Rumyantseva, T. V. Nasedkina, T. V. Savitskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-17 (2022)
The use of all-trans retinoic acid (ATRA) drastically improved the results of therapy for acute promyelocytic leukeimia (APL). The high efficiency of the Russian protocol APL-93—98 applied to 62 children and adolescents with APL (event-free and ove
Externí odkaz:
https://doaj.org/article/a1999c503e6849b689ddc0507d049b22
Autor:
R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:12-31
Introduction. Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS have an increased risk of developing acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat ALL in children with Down syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f036e3dafc5f4f57b9d14b9e3cca4c8c
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
Autor:
D. V. Litvinov, I. P. Tesakov, L. N. Shelikhova, L. A. Khachatryan, E. A. Zerkalenkova, Yu. V. Olshanskaya, A. Yu. Komkov, A. M. Popov, E. V. Mikhaylova, A. N. Remizov, N. V. Myakova, Yu. V. Rumyantseva, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:100-114
Acute lymphoblastic leukemia (ALL) with translocation t(17;19)(q21-q22;p13) TCF3::HLF (E2A::HLF) accounts for less than 1% of childhood B-lineage ALL. Since the first description, patients with this type of ALL are stratified into high-risk group. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aec2a96dd7cb5690f86a0d870df79001
https://doi.org/10.24287/1726-1708-2022-21-3-100-114
https://doi.org/10.24287/1726-1708-2022-21-3-100-114
Autor:
D. V. Litvinov, N. V. Myakova, O. V. Aleynikova, L. G. Fechina, L. M. Minkina, K. L. Kondratchik, E. V. Inyushkina, K. S. Aslanyan, O. V. Ryskal, L. I. Zharikova, O. I. Bydanov, S. N. Lagoyko, Yu. V. Rumyantseva, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:28-41
This paper presents the results for the patients with acute lymphoblastic leukemia (ALL) from the high-risk group (HRG) treated according to the ALL-MB 2002 Protocol. The registration phase of the study was performed from 15.04.2002 to 01.01.2008. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a33a652fa2728f61812551b22b106d89
https://doi.org/10.24287/1726-1708-2022-21-3-28-41
https://doi.org/10.24287/1726-1708-2022-21-3-28-41
Autor:
A. M. Popov, Y. Yu. Verzhbitskaya, G. A. Tsaur, A. G. Solodovnikov, O. R. Arakaev, O. V. Streneva, O. P Khlebnikova, E. V. Shorikov, L. I. Saveliev, S. N. Lagoyko, Yu. V. Rumyantseva, A. I. Karachunskiy, L. G. Fechina
Publikováno v:
Онкогематология, Vol 10, Iss 4, Pp 44-55 (2015)
191 consecutive unselected children with acute lymphoblastic leukemia aged from 1 to 16 years were enrolled in the study. Bone marrow samples were obtained at the time of initial diagnostics as well as at days 15 (n = 188), 36 (n = 191), and 85 (n =
Externí odkaz:
https://doaj.org/article/0218a3540de14fb58723611f40943264